MarketPeel
Insider Trading Intelligence
Pricing
…
DM

Dale Muzzey

MYGN
CHIEF SCIENTIFIC OFFICER · MYRIAD GENETICS INC · CIK 0001922964
FILING MIX · LIFETIME18%/82%
BUYS
7
SELLS
33
TOTAL VALUE
$733.7K
COMPANIES
1
ACTIVE SINCE
Apr 2022
HOLDINGS NOW
326,310
AVG SELL PX
$9.35
TRADE KIND
SHOWING 40 / 40
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Dale Muzzey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+8.33%+1.26%+7.07%+7.07%—
14d1+100.00%-0.72%+3.13%-3.86%-3.86%—
30d1+100.00%-8.37%+4.86%-13.23%-13.23%—
60d1+100.00%-34.13%+8.33%-42.46%-42.46%—
90d1+100.00%-41.63%+9.06%-50.69%-50.69%—
180d1+100.00%-63.47%+1.76%-65.23%-65.23%—
1y1+100.00%-70.78%+19.74%-90.52%-90.52%—
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MYGN · 326,310 shares · as of Apr 14, 2026
091,769183,537275,306367,0742023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 7 buys / 33 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
946$4.91$4.6K326,310Apr 14, 2026Apr 15, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
2,019$4.58$9.2K327,256Mar 22, 2026Mar 23, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
4,783$4.66$22.3K341,224Mar 15, 2026Mar 16, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
11,949$4.66$55.7K329,275Mar 15, 2026Mar 16, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
8,288$4.66$38.6K346,007Mar 14, 2026Mar 16, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
12,779$4.66$59.6K354,295Mar 13, 2026Mar 16, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
173,196——367,074Mar 12, 2026Mar 16, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
23,697——193,878Feb 2, 2026Feb 3, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
418$6.15$2.6K170,181Jan 1, 2026Jan 2, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
942$8.08$7.6K170,599Apr 14, 2025Apr 15, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
545$9.98$5.4K172,341Mar 24, 2025Mar 25, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
800$9.98$8.0K171,541Mar 24, 2025Mar 25, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
2,011$10.01$20.1K178,220Mar 22, 2025Mar 25, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
5,334$10.01$53.4K172,886Mar 22, 2025Mar 25, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
4,764$10.07$48.0K180,231Mar 15, 2025Mar 17, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
8,544$10.07$86.0K184,995Mar 14, 2025Mar 17, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
75,773——193,539Mar 13, 2025Mar 17, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
10,622——117,766Feb 7, 2025Mar 4, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
417$13.71$5.7K107,144Jan 1, 2025Jan 2, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
452$24.37$11.0K107,561Oct 9, 2024Oct 10, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
2,100$26.17$55.0K108,013Sep 11, 2024Sep 12, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
940$19.55$18.4K110,113Apr 14, 2024Apr 15, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
382$22.24$8.5K111,614Mar 24, 2024Mar 25, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
561$22.24$12.5K111,053Mar 24, 2024Mar 25, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
1,405$22.24$31.2K111,996Mar 22, 2024Mar 25, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
3,322$21.16$70.3K113,401Mar 15, 2024Mar 18, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
49,250——116,723Mar 14, 2024Mar 18, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
303$19.14$5.8K67,473Jan 1, 2024Jan 2, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
308$15.01$4.6K67,776Oct 9, 2023Oct 10, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
133$15.99$2.1K68,084Sep 26, 2023Sep 27, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
638$22.27$14.2K68,217Apr 14, 2023Apr 17, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
545$23.72$12.9K68,855Mar 24, 2023Mar 27, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
372$23.72$8.8K69,400Mar 24, 2023Mar 27, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
1,399$22.91$32.1K69,772Mar 22, 2023Mar 23, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
28,459——71,171Mar 15, 2023Mar 16, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
302$14.51$4.4K42,712Jan 1, 2023Jan 4, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
309$19.62$6.1K43,014Oct 9, 2022Oct 11, 2022 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
133$18.41$2.4K43,323Sep 26, 2022Sep 27, 2022 ↗View →
MYGN
MYRIAD GENETICS INC
SALE
Chief Scientific Officer
345$18.69$6.4K43,456Sep 25, 2022Sep 27, 2022 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
7,500——43,801Apr 14, 2022Apr 14, 2022 ↗View →
Other insiders · MYGN
Loading peer insiders…
About this filer
CIK 0001922964
ROLE
Chief Scientific Officer
PRIMARY
MYGN
COMPANIES
1
ACTIVE SINCE
Apr 2022
MARKETPEEL · /INSIDER/0001922964DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback